Molecular Advances in New Combination Therapies for Cancer

Dear Colleagues,

Increasingly, combination therapies are being used to treat many cancer patients. These treatments combine two or more drugs or therapies, such as chemotherapy, radiotherapy and immunotherapy. In recent decades, immunotherapy and targeted therapy have emerged as revolutionary options for cancer treatment, improving the survival of cancer patients. However, because tumors can become resistant to drugs and immunotherapy can only be used on a subset of patients, it is essential to find alternative therapeutic strategies. Therefore, the use of combination therapies represents a successful innovative strategy for cancer treatment and is more effective than monotherapy because it acts synergistically or additively on key pathways. Understanding the molecular biological characteristics of cancer facilitates the development of new approaches for combination therapies.

The purpose of this Special Issue is to collect original preclinical research articles or reviews on recent advances in the development of combination therapies used to treat cancer.

Dr. Valeria Lucarini
Dr. Camilla Palumbo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.